- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.83 Å
- Oligo State
- monomer
- Ligands
- 6 x GOL: GLYCEROL(Non-functional Binders)
- 4 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.3: 4 residues within 4Å:- Chain A: N.380, Y.382, T.844, Y.884
2 PLIP interactions:2 interactions with chain A- Water bridges: A:Y.382, A:Y.884
DMS.5: 5 residues within 4Å:- Chain A: P.505, E.506, N.507, G.508, Y.564
1 PLIP interactions:1 interactions with chain A- pi-Cation interactions: A:Y.564
DMS.7: 3 residues within 4Å:- Chain A: H.693, V.694, D.695
2 PLIP interactions:2 interactions with chain A- Water bridges: A:V.694
- Salt bridges: A:D.695
DMS.10: 5 residues within 4Å:- Chain A: N.280, I.290, S.293, R.296, E.769
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:E.769
- 1 x X4I: N~2~-(3,5-difluorophenyl)-N-[(1R)-2-(hydroxyamino)-2-oxo-1-(3',4',5'-trifluoro[1,1'-biphenyl]-4-yl)ethyl]glycinamide(Non-covalent)
X4I.6: 23 residues within 4Å:- Chain A: T.112, Q.124, E.126, A.127, N.265, V.266, G.267, A.268, M.269, E.270, H.303, E.304, H.307, E.326, M.378, E.379, Y.382, T.383, T.384, Y.387, M.841
- Ligands: GOL.1, ZN.12
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:V.266, A:V.266, A:Y.382, A:Y.382, A:Y.387
- Hydrogen bonds: A:G.267, A:A.268, A:Y.387, A:Y.387
- Water bridges: A:R.296
- pi-Stacking: A:Y.382
- Halogen bonds: A:N.265, A:M.378
- 1 x ZN: ZINC ION(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.13: 1 residues within 4Å:- Chain A: E.764
No protein-ligand interaction detected (PLIP)MG.14: 1 residues within 4Å:- Chain A: G.57
6 PLIP interactions:1 interactions with chain A, 5 Ligand-Water interactions- Metal complexes: A:G.57, H2O.10, H2O.21, H2O.21, H2O.27, H2O.31
MG.15: 1 residues within 4Å:- Chain A: D.245
No protein-ligand interaction detected (PLIP)MG.16: 1 residues within 4Å:- Chain A: N.890
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Calic, P.P.S. et al., Structure-based development of potent Plasmodium falciparum M1 and M17 aminopeptidase selective and dual inhibitors via S1'-region optimisation. Eur.J.Med.Chem. (2022)
- Release Date
- 2023-01-18
- Peptides
- M1 family aminopeptidase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.83 Å
- Oligo State
- monomer
- Ligands
- 6 x GOL: GLYCEROL(Non-functional Binders)
- 4 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 1 x X4I: N~2~-(3,5-difluorophenyl)-N-[(1R)-2-(hydroxyamino)-2-oxo-1-(3',4',5'-trifluoro[1,1'-biphenyl]-4-yl)ethyl]glycinamide(Non-covalent)
- 1 x ZN: ZINC ION(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Calic, P.P.S. et al., Structure-based development of potent Plasmodium falciparum M1 and M17 aminopeptidase selective and dual inhibitors via S1'-region optimisation. Eur.J.Med.Chem. (2022)
- Release Date
- 2023-01-18
- Peptides
- M1 family aminopeptidase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A